| CTRI Number |
CTRI/2025/04/085914 [Registered on: 29/04/2025] Trial Registered Prospectively |
| Last Modified On: |
25/04/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Surgical/Anesthesia Dentistry |
| Study Design |
Randomized, Parallel Group, Multiple Arm Trial |
|
Public Title of Study
|
Comparing Different Treatments to Heal Bone Loss Caused by Severe Gum Disease Using Laser Therapy, Natural Proteins, and Growth Factors |
|
Scientific Title of Study
|
CLINICAL AND RADIOGRAPHICAL EVALUATION OF PHOTOBIOMODULATION WITH ENAMEL MATRIX DERIVATIVE (EMD) AND CONCENTRATED GROWTH FACTOR (CGF) IN THE MANAGEMENT OF INTRABONY PERIODONTAL DEFECTS IN STAGE III or IV PERIODONTITIS PATIENTS: A MULTI ARM PARALLEL GROUP RANDOMIZED TRIAL |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
SIVSRI ROSHAN G M |
| Designation |
Post graduate student |
| Affiliation |
SRM Dental College Ramapuram |
| Address |
Department of peridontology,
SRM Dental College,
Bharathi Salai,
Ramapuram,
Chennai.
Chennai TAMIL NADU 600089 India |
| Phone |
7010561672 |
| Fax |
|
| Email |
sivsri10474@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
DR DHAYANAND JOHN VICTOR |
| Designation |
HOD, Professor of Department of Periodontics |
| Affiliation |
SRM Dental College Ramapuram |
| Address |
Department of peridontology,
SRM Dental College,
Bharathi Salai,
Ramapuram,
Chennai.
Chennai TAMIL NADU 600089 India |
| Phone |
9841009952 |
| Fax |
|
| Email |
dr.djvictor@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
DHAYANAND JOHN VICTOR |
| Designation |
HOD, Professor of Department of Periodontics |
| Affiliation |
SRM Dental College Ramapuram |
| Address |
Department of peridontology,
SRM Dental College,
Bharathi Salai,
Ramapuram,
Chennai.
Chennai TAMIL NADU 600089 India |
| Phone |
9841009952 |
| Fax |
|
| Email |
dr.djvictor@gmail.com |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
SIVSRI ROSHAN G M |
| Address |
1st Year MDS Student,
Department of periodontics,
SRM Dental College,
Bharathi Salai,
Ramapuram,
Chennai-89. |
| Type of Sponsor |
Other [Self funded] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| DR SIVSRI ROSHAN G M |
SRM Dental College Ramapuram |
Department of Periodontics,
SRM Dental College,
Bharathi Salai,
Ramapuram,
Chennai-89. Chennai TAMIL NADU |
7010561672
sivsri1074@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| INSTITUTIONAL REVIEW BOARD |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: K053||Chronic periodontitis, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Periodontal Regeneration in Intrabony defects using Photobimodulation |
15 sites with 2 or 3 walled defects in Stage III or IV Periodontal Diseases treated with open flap debridement and photobiomodulation |
| Intervention |
Periodontal Regeneration in Intrabony defects using Photobimodulation and Emdogain |
15 sites with 2 or 3 walled defects in Stage III or IV Periodontal Diseases treated with open flap debridement and photobiomodulation and Emdogain |
| Intervention |
Periodontal Regeneration in Intrabony defects using Photobimodulation, Emdogain and Concentrated Growth Factor
|
15 sites with 2 or 3 walled defects in Stage III or IV Periodontal Diseases treated with open flap debridement and photobiomodulation, Emdogain and Concentrated Growth Factor |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
Patients with an age range of 18 to 60.
Patients with probing pocket depth greater than or equal to 6 mm and clinical attachment loss of greater than or equal to 3 mm.
Patients with 2 walled or 3 walled intrabony defects, with a defect depth of greater than or equal to 3 mm.
Full-mouth plaque score (FMPS) less than 20 percent after phase I therapy
Full-mouth bleeding score(FMBS) less than 20 percent after phase I therapy
Systemically healthy patients; with no disease that will have a bearing on the outcome of the surgical intervention
|
|
| ExclusionCriteria |
| Details |
Patients diagnosed with mal-alignment at the defect site
Patients with systemic disease or drugs that contraindicate periodontal surgery.
Patients with a history of smoking and pan chewing.
Sites with advanced furcation involvement.
Pregnant and lactating women |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
To evaluate and compare the following clinical outcome measures:
1.Clinical Attachment Level gain (CAL) between groups.
2.Probing Pocket Depth (PPD) reduction between groups.
3.Radiographic bone fill between the groups |
Baseline
1 month
3 month
6 month
12 month |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To evaluate and compare the position of the gingival crest between the groups. |
Baseline
1 month
3 month
6 month
12 month |
|
|
Target Sample Size
|
Total Sample Size="55" Sample Size from India="55"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
28/05/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Regenerative Management of Periodontal Intrabony Defects Periodontal intrabony defects present a significant clinical challenge, often threatening tooth stability. Regenerative therapies aim to restore lost bone and supporting tissues, improving both function and aesthetics while preserving natural dentition. Photobiomodulation (PBM) at 650 nm offers a non-invasive adjunctive treatment that promotes periodontal regeneration. It enhances fibroblast activity, collagen synthesis, angiogenesis, and growth factor production, while also reducing inflammation. These effects accelerate healing and improve clinical outcomes, including attachment gain and probing depth reduction. Enamel Matrix Derivative (EMD), derived from developing enamel, stimulates the proliferation and differentiation of cells critical for periodontal regeneration. EMD promotes cementum and periodontal ligament formation, enhances angiogenesis, modulates inflammation, and supports new bone growth, leading to improved clinical attachment and radiographic bone fill. Concentrated Growth Factor (CGF), an autologous platelet-rich plasma derivative, is rich in growth factors that promote cell proliferation and differentiation. CGF enhances wound healing through angiogenesis and inflammation reduction, contributing to effective bone and tissue regeneration. Combining PBM, EMD, and CGF may provide a synergistic effect, amplifying individual benefits. PBM improves healing dynamics and growth factor activity, EMD stimulates tissue regeneration, and CGF accelerates repair. Together, they may significantly enhance the regenerative response in intrabony defects, offering a superior alternative to conventional therapies with improved long-term outcomes. |